Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$319K Sell
6,631
-1,992
-23% -$92.9K ﹤0.01% 1140
2025
Q4
$418K Buy
8,623
+2,430
+39% +$120K ﹤0.01% 906
2025
Q3
$292K Sell
6,193
-1,206
-16% -$58.2K ﹤0.01% 1047
2025
Q2
$357K Buy
7,399
+959
+15% +$49K ﹤0.01% 885
2025
Q1
$357K Buy
6,440
+79
+1% +$4.28K ﹤0.01% 771
2024
Q4
$307K Buy
6,361
+1,264
+25% +$64.3K ﹤0.01% 1101
2024
Q3
$294K Buy
5,097
+369
+8% +$19.9K ﹤0.01% 1098
2024
Q2
$229K Buy
+4,728
New +$228K ﹤0.01% 1086
2023
Q4
Sell
-3,865
Closed -$207K 870
2023
Q3
$207K Buy
+3,865
New +$206K ﹤0.01% 751

Other funds holding SNY

Savant Capital's SNY Position: Q1 2026 in Review

Savant Capital reduced its Sanofi (SNY) stake by 23% in Q1 2026, selling an estimated $92.9K and leaving 6,631 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #1140.

Savant Capital first reported a position in SNY in Q3 2023 and has held it in 9 quarters since. The position peaked at $418K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Savant Capital held 6,631 shares of Sanofi worth $319K as of Q1 2026.
  • Savant Capital sold 1,992 Sanofi shares in Q1 2026, an estimated $92.9K.
  • Sanofi made up ﹤0.01% of Savant Capital's portfolio in Q1 2026, its #1140 holding.
  • Savant Capital first reported a position in Sanofi in Q3 2023 and has held it in 9 quarters since.
  • Savant Capital's Sanofi position peaked at $418K in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Savant Capital's 13F filing for Q1 2026, filed 4 May 2026.